Dominique Farge-Bancel

Summary

Country: France

Publications

  1. pmc Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research group
    Chingching Foocharoen
    Department of Rheumatology, Basel University, Burgfelderstrasse 101, Basel 4012, Switzerland
    Arthritis Res Ther 14:R37. 2012
  2. doi request reprint Autologous stem cell transplantation for systemic sclerosis
    Dominique Farge
    Service de Medecine Interne, Hopital Saint Louis, Paris, France
    Autoimmunity 41:616-24. 2008
  3. pmc Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases
    Dominique Farge
    Service de Médecine Interne et Unité INSERM U 976, Hopital Saint Louis, Assistance Publique Hopitaux de Paris, Paris 7 Université Denis Diderot, 1 avenue Claude Vellefaux, 75 010 Paris France
    Haematologica 95:284-92. 2010
  4. doi request reprint Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients
    Dominique Farge
    Service de médecine interne et pathologie vasculaire, Hôpital Saint Louis and INSERM U976, Assistance Publique Hopitaux de Paris, Paris, France
    Thromb Res 125:S108-16. 2010
  5. ncbi request reprint [Bone marrow transplantation in the treatment of autoimmune disease]
    D Farge
    Service de médecine interne et pathologie vasculaire, Hopital Saint Louis, INSERM U697, 1 avenue Claude Vellefaux, 75010 Paris, France
    Rev Med Interne 28:S285-7. 2007
  6. ncbi request reprint Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study
    Dominique Farge
    Service de Medecine Interne, site transfusionnel de Saint Louis, France
    Br J Haematol 119:726-39. 2002
  7. ncbi request reprint In vitro evidence for a direct antifibrotic role of the immunosuppressive drug mycophenolate mofetil
    Nina Roos
    Institut National de la Santé et de la Recherche Médicale U697, Hopital Saint Louis, Pavillon Bazin, 1 avenue Claude Vellefaux, 75010 Paris, France
    J Pharmacol Exp Ther 321:583-9. 2007
  8. ncbi request reprint Involvement of ERK signaling in halofuginone-driven inhibition of fibroblast ability to contract collagen lattices
    Charlotte Tacheau
    INSERM U697, 1 avenue Claude Vellefaux, 75010 Paris, France
    Eur J Pharmacol 573:65-9. 2007
  9. doi request reprint Autologous hematopoietic stem cell transplant in systemic sclerosis: quantitative high resolution computed tomography of the chest scoring
    David Launay
    Service de Medecine Interne, Hopital Claude Huriez, Universite Lille 2, Lille, France
    J Rheumatol 36:1460-3. 2009
  10. ncbi request reprint Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis
    Dominique Farge
    Hopital Saint Louis, Paris, France
    Arthritis Rheum 52:1555-63. 2005

Detail Information

Publications36

  1. pmc Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research group
    Chingching Foocharoen
    Department of Rheumatology, Basel University, Burgfelderstrasse 101, Basel 4012, Switzerland
    Arthritis Res Ther 14:R37. 2012
    ..Erectile dysfunction (ED) is common in men with systemic sclerosis (SSc) but the demographics, risk factors and treatment coverage for ED are not well known...
  2. doi request reprint Autologous stem cell transplantation for systemic sclerosis
    Dominique Farge
    Service de Medecine Interne, Hopital Saint Louis, Paris, France
    Autoimmunity 41:616-24. 2008
    ..This review reports the current data concerning the effects of HSCT on survival, skin, and major organ function in patients with severe dcSSc...
  3. pmc Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases
    Dominique Farge
    Service de Médecine Interne et Unité INSERM U 976, Hopital Saint Louis, Assistance Publique Hopitaux de Paris, Paris 7 Université Denis Diderot, 1 avenue Claude Vellefaux, 75 010 Paris France
    Haematologica 95:284-92. 2010
    ..We evaluated the long-term outcomes of these transplants and aimed to identify potential prognostic factors...
  4. doi request reprint Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients
    Dominique Farge
    Service de médecine interne et pathologie vasculaire, Hôpital Saint Louis and INSERM U976, Assistance Publique Hopitaux de Paris, Paris, France
    Thromb Res 125:S108-16. 2010
    ....
  5. ncbi request reprint [Bone marrow transplantation in the treatment of autoimmune disease]
    D Farge
    Service de médecine interne et pathologie vasculaire, Hopital Saint Louis, INSERM U697, 1 avenue Claude Vellefaux, 75010 Paris, France
    Rev Med Interne 28:S285-7. 2007
  6. ncbi request reprint Autologous bone marrow transplantation in the treatment of refractory systemic sclerosis: early results from a French multicentre phase I-II study
    Dominique Farge
    Service de Medecine Interne, site transfusionnel de Saint Louis, France
    Br J Haematol 119:726-39. 2002
    ..Non-myeloablative conditioning, followed by a T cell-depleted autologous PBSC or bone marrow transplantation, appears feasible with low toxicity in severe SSc with short-term clinical benefits...
  7. ncbi request reprint In vitro evidence for a direct antifibrotic role of the immunosuppressive drug mycophenolate mofetil
    Nina Roos
    Institut National de la Santé et de la Recherche Médicale U697, Hopital Saint Louis, Pavillon Bazin, 1 avenue Claude Vellefaux, 75010 Paris, France
    J Pharmacol Exp Ther 321:583-9. 2007
    ..g., collagen production, extracellular matrix contraction, and cell migration. Such properties may contribute to the beneficial therapeutic effects of MMF against fibrotic lesions developing in systemic sclerosis or during GVHD...
  8. ncbi request reprint Involvement of ERK signaling in halofuginone-driven inhibition of fibroblast ability to contract collagen lattices
    Charlotte Tacheau
    INSERM U697, 1 avenue Claude Vellefaux, 75010 Paris, France
    Eur J Pharmacol 573:65-9. 2007
    ..These data thus indicate that the inhibitory effect of halofuginone on fibroblast contractile activity, a key function for wound healing implicated in the development of tissue fibrosis, is an ERK-mediated mechanism...
  9. doi request reprint Autologous hematopoietic stem cell transplant in systemic sclerosis: quantitative high resolution computed tomography of the chest scoring
    David Launay
    Service de Medecine Interne, Hopital Claude Huriez, Universite Lille 2, Lille, France
    J Rheumatol 36:1460-3. 2009
    ..Using high resolution computed tomography (HRCT), to assess the lung involvement outcome after autologous hematopoietic stem cell transplant (AHSCT) in patients with scleroderma (systemic sclerosis, SSc)...
  10. ncbi request reprint Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis
    Dominique Farge
    Hopital Saint Louis, Paris, France
    Arthritis Rheum 52:1555-63. 2005
    ..To analyze hematopoietic and immune reconstitution after autologous hematopoietic stem cell transplantation (HSCT) in 7 patients with systemic sclerosis (SSc)...
  11. ncbi request reprint Impact of pain in health related quality of life of patients with systemic sclerosis
    C Georges
    Internal Medicine Department, Saint Louis Hospital, Service de Medecine Interne, Hopital Saint Louis, 1 avenue Claude Vellefaux, 75010 Paris, France
    Rheumatology (Oxford) 45:1298-302. 2006
    ..The aim of the study is as to evaluate the quality of life (QoL) in patients with either diffuse or limited SSc, and to examine the impact of pain on the QoL scores...
  12. ncbi request reprint Transforming growth factor-beta signaling through the Smad proteins: role in systemic sclerosis
    Franck Verrecchia
    INSERM U697, Hopital Saint Louis, Pavillon Bazin, 1 avenue Claude Vellefaux, Paris, France
    Autoimmun Rev 5:563-9. 2006
    ..Potential implications for the development of therapeutic approaches against tissue fibrosis during SSc are discussed...
  13. ncbi request reprint Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study
    Guy Meyer
    Department of Respiratory and Critical Care Medicine, Hopital Europeen Georges Pompidou, Paris V University, France
    Arch Intern Med 162:1729-35. 2002
    ..The use of low-molecular-weight heparin sodium for secondary prevention of venous thromboembolism in cancer patients may reduce the complication rate...
  14. ncbi request reprint [Cardiopulmonary function before and after cyclophosphamide treatment in severe systemic sclerosis: comparison of monthly intravenous bolus and autologous haematopoietic stem cell transplantation]
    C Toledano
    Service de Medecine Interne, Hopital Saint Louis, Paris, France
    Rev Med Interne 26:444-52. 2005
    ..Cyclophosphamide potential cardiotoxicity in this setting has been questioned...
  15. ncbi request reprint [Quality of life assessment with the MOS-SF36 in patients with systemic sclerosis]
    C Georges
    Service de Medecine Interne, Hopital Saint Louis, 1, avenue Claude Vellefaux, 75475 Paris 10, France
    Rev Med Interne 25:16-21. 2004
    ....
  16. ncbi request reprint Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ)
    C Georges
    AP HP, Internal Medicine, Saint Louis Hospital, 1 avenue Claude Vellefaux, 75010 Paris, France
    Clin Rheumatol 24:3-10. 2005
    ..In addition, we suggest the use of a new outcome measure, the SSc HAQ score, to assess this systemic disease more accurately...
  17. doi request reprint Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie)
    Kiet Phong Tiev
    Service de Medecine Interne, Hopital Saint Antoine, Paris, France
    J Rheumatol 36:1470-6. 2009
    ..This cross-sectional analysis of a large multicenter cohort compared the characteristics of SSc patients with prior or current digital ulcers with those never affected...
  18. doi request reprint Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis
    Julie Baraut
    INSERM U976, Pavillon Bazin, Hopital Saint Louis, 1 avenue Claude Vellefaux, 75010 Paris, France
    Autoimmun Rev 10:65-73. 2010
    ..Restoration of the Th1/Th2/Th17/Treg balance is one of the hallmarks of treatment effectiveness and development of cytokine modulators could be considered for new therapeutic approaches in SSc patients...
  19. ncbi request reprint [Therapeutic intensification and autologous stem cell transplantation in autoimmune diseases]
    Z Marjanovic
    Service de Medecine Interne, Service de Greffe de Moelle, Hopital Saint Louis, 1, avenue Claude Vellefaux, 75010 Paris, France
    Presse Med 34:311-8. 2005
    ..A STUDY PROJECT IS PLANNED FOR MULTIPLE SCLEROSIS (Astims, Autologous Stem cell Transplantation International Multiple Sclerosis)...
  20. doi request reprint [Mesenchymal stem cells and immunomodulation: toward new immunosuppressive strategies for the treatment of autoimmune diseases?]
    J Larghero
    Unité de Thérapie Cellulaire, Hopital Saint Louis, AP HP, Paris, France
    Rev Med Interne 30:287-99. 2009
    ..Phase I-II studies are in progress in various countries to investigate the potential benefit from MSC due to their immunosuppressive properties, as an adjunctive therapy for severe refractory autoimmune disease...
  21. ncbi request reprint Arterial stiffness predicts severe progression in systemic sclerosis: the ERAMS study
    Joel Constans
    Vascular and Internal Medicine Unit, CHU Bordeaux, Paris, France
    J Hypertens 25:1900-6. 2007
    ..The ERAMS study addressed the value of arterial stiffness in predicting the severity of systemic sclerosis...
  22. ncbi request reprint Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis
    J Larghero
    Cell Therapy Unit, Assistance Publique Hopitaux de Paris, Saint Louis Hospital, Paris, France
    Ann Rheum Dis 67:443-9. 2008
    ..Mesenchymal stem cells (MSCs) have a potential immunomodulatory role in autoimmune disease; however, the qualitative properties and haematopoietic support capacity of MSCs derived from patients with autoimmune disease is unclear...
  23. pmc Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry
    D Farge
    St Louis Hospital, Paris, France
    Ann Rheum Dis 63:974-81. 2004
    ..This EBMT/EULAR report describes the longer outcome of patients originally described in addition to newly recruited cases...
  24. ncbi request reprint Evidence of an antifibrotic effect of immunosuppressive drugs: applications in the treatment of systemic sclerosis
    Franck Verrecchia
    INSERM U697, , 1 avenue Claude Vellefaux, 75010 Paris, France
    Expert Rev Clin Immunol 5:35-43. 2009
    ..Since 1996, this drug has been used at higher doses for autologous hematopoietic stem cell transplantations, permitting rapid and durable clinical and histological regression of skin fibrosis...
  25. doi request reprint 2008 French national guidelines for the treatment of venous thromboembolism in patients with cancer: report from the working group
    Dominique Farge
    Service de médecine interne et pathologie vasculaire, Hopital Saint Louis, Assistance Publique Hôpitaux de Paris and INSERM U976, Paris VII University, France
    Crit Rev Oncol Hematol 73:31-46. 2010
    ....
  26. ncbi request reprint [Vulnerable populations: risk factors and evaluation. Measures of protection]
    Marjan Daneshpouy
    Service de Medecine Interne, Hopital Saint Louis, 75010 Paris
    Rev Prat 55:887-92. 2005
  27. ncbi request reprint Modulation of collagen and MMP-1 gene expression in fibroblasts by the immunosuppressive drug rapamycin. A direct role as an antifibrotic agent?
    Nicolas Poulalhon
    INSERM U697, Hopital Saint Louis, 75010 Paris, France
    J Biol Chem 281:33045-52. 2006
    ..It thus appears that rapamycin may exert direct antifibrotic activities independent from its immunosuppressive action...
  28. ncbi request reprint Skin involvement in scleroderma--where histological and clinical scores meet
    F Verrecchia
    INSERM U697, Paris, France
    Rheumatology (Oxford) 46:833-41. 2007
    ....
  29. doi request reprint [Hospital LOS, medical complexity and deprivation indicators]
    J Holstein
    Département d information médicale, Assistance Publique Hopitaux de Paris, Paris Cedex 04, France
    Rev Epidemiol Sante Publique 57:205-11. 2009
    ..Hence, we aimed at extracting routinely available variables measuring deprivation from the Hospital Information System and at assessing their association with severity of illness and hospital LOS...
  30. doi request reprint Azathioprine or methotrexate maintenance for ANCA-associated vasculitis
    Christian Pagnoux
    Universite Paris Descartes, Hopital Cochin, Assistance Publique Hopitaux de Paris, Paris, France
    N Engl J Med 359:2790-803. 2008
    ..However, azathioprine and methotrexate have not been compared with regard to safety and efficacy...
  31. ncbi request reprint Prognostic value of quantitative Kaposi sarcoma--associated herpesvirus load in posttransplantation Kaposi sarcoma
    Claire Pellet
    Laboratory of Pharmacology, Hopital Saint Louis, Paris, France
    J Infect Dis 186:110-3. 2002
    ..01). Thus, quantification of KSHV load in peripheral blood mononuclear cells could represent a useful tool for monitoring transplant recipients with KS...
  32. doi request reprint [Follow-up with the assistance of TB-info software of 208 tuberculosis patients who were treated in 2004]
    A Bourgarit
    Hopital Saint Louis, Paris, France
    Rev Med Interne 30:841-6. 2009
    ..The impact of the TB-info software was assessed on the care of patients treated with antituberculosis regimen (ATT)...
  33. doi request reprint Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes
    L Vija
    INSERM U697, Paris, France
    Diabetes Metab 35:85-93. 2009
    ..In this review, we provide a brief characterization of MSC immunomodulatory effects, and present the current experimental evidence for the potential therapeutic efficacy of MSC transplantation in diabetes...
  34. doi request reprint Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database
    Christian Pagnoux
    Universite Paris Descartes, Hopital Cochin, Assistance Publique Hopitaux de Paris, Paris, France
    Arthritis Rheum 62:616-26. 2010
    ..This study was undertaken to describe the main characteristics of and long-term outcomes in patients with well-characterized PAN diagnoses...
  35. doi request reprint European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research
    J Avouac
    Rheumatology A Department, RDU, Paris, France
    Ann Rheum Dis 68:629-34. 2009
    ..In particular, the results of a web-based Delphi exercise aimed at selection of research questions and evidence from systematic literature research, as parts of the development of these recommendations, are presented in detail...
  36. ncbi request reprint Autologous stem cell transplantation for systemic lupus erythematosus
    David Jayne
    Department of Medicine, Addenbrooke s Hospital, Cambridge, UK
    Lupus 13:168-76. 2004
    ..The safety of this procedure is likely to be improved by patient selection and choice of conditioning regimen. The return of disease activity in one-third of patients might be reduced by long-term immunosuppressive therapy post-ASCT...